Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function

Combination therapy using T cell redirection antigen binding molecule against cell having immunosuppressing function

US Patent 11660340 · Granted May 30, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Device for carrying syringes2025
Device for carrying syringes2025
Speaker2025
Anti-CTLA-4 antibody and use thereof2025
Anti-CD137 antigen-binding molecule and utilization thereof2025
Compound having affinity substance to soluble protein, cleavable portion and rea2024
Antigen-binding molecule comprising altered antibody variable region binding CD32024
Method for screening for cancer therapeutic agent2022
Immunoactivating antigen-binding molecule2022
Immunoactivating antigen-binding molecule2022
Cell injury inducing therapeutic drug for use in cancer therapy2021
Process for producing antibodies2013